Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.

[1]  J. Finnegan,et al.  PULMONARY ARTERIOVENOUS FISTULA (VARIX): Review of the Literature and Report of Two Cases , 1949 .

[2]  D. Cooley,et al.  Pulmonary telangiectasia: report of case proved by pulmonary biopsy. , 1954, The Journal of thoracic surgery.

[3]  M. Hales.  Multiple small arteriovenous fistulae of the lungs. , 1956, The American journal of pathology.

[4]  S. Glagov,et al.  A Lamellar Unit of Aortic Medial Structure and Function in Mammals , 1967, Circulation research.

[5]  D. Perl,et al.  Neurological manifestations of hereditary hemorrhagic telangiectasia (rendu‐osler‐weber disease): Report of 2 cases and review of the literature , 1978, Annals of neurology.

[6]  P. Vase,et al.  Histological findings following oestrogen treatment of hereditary haemorrhagic telangiectasia , 1983, The Journal of Laryngology & Otology.

[7]  P. Brasseur,et al.  High-output right ventricular failure secondary to hepatic arteriovenous microfistulae. Selective arterial embolization treatment. , 1984, Archives of internal medicine.

[8]  S. Bown,et al.  Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. , 1985, Gut.

[9]  A. Knudson.  Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[10]  A. J. Swinburne,et al.  Hereditary telangiectasia and multiple pulmonary arteriovenous fistulas. Clinical deterioration during pregnancy. , 1986, Chest.

[11]  [Video-microscopic studies of telangiectases in Osler's disease and scleroderma]. , 1986, Schweizerische medizinische Wochenschrift.

[12]  I. Wanless,et al.  Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. , 1986, Archives of pathology & laboratory medicine.

[13]  M. Pras,et al.  Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telangiectasia. , 1988, Southern medical journal.

[14]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[15]  H. Plauchu,et al.  Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. , 1989, American journal of medical genetics.

[16]  I M Braverman,et al.  Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. , 1989, The Journal of investigative dermatology.

[17]  B. Jacobson,et al.  Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. , 1990, The Journal of investigative dermatology.

[18]  P. Rutgeerts,et al.  Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone , 1990, The Lancet.

[19]  F. Keller,et al.  Osler-Weber-Rendu disease and pulmonary arteriovenous fistulas. Deterioration and embolotherapy during pregnancy. , 1990, Chest.

[20]  Robert I. White,et al.  The natural history of epistaxis in hereditary hemorrhagic telangiectasia , 1991, The Laryngoscope.

[21]  M. Porteous,et al.  Hereditary haemorrhagic telangiectasia: a clinical analysis. , 1992, Journal of medical genetics.

[22]  E. Heyer,et al.  An abnormal concentration of cases of Rendu-Osler disease in the Valserine valley of the French Jura: a genealogical and demographic study. , 1992, Annals of human biology.

[23]  Antibiotic prophylaxis for patients with hereditary hemorrhagic telangiectasia. , 1992, Journal of the American Academy of Dermatology.

[24]  H. Saba,et al.  Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. , 1994, The New England journal of medicine.

[25]  Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. , 1994, The New England journal of medicine.

[26]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.

[27]  J. Hughes,et al.  A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3 , 1994, Nature Genetics.

[28]  A. Guttmacher,et al.  Hereditary hemorrhagic telangiectasia. , 1995, The New England journal of medicine.

[29]  J. Hughes,et al.  Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. , 1995, QJM : monthly journal of the Association of Physicians.

[30]  D. W. Johnson,et al.  Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.

[31]  J. T. ten Berg,et al.  Unusual complications after embolization of a pulmonary arteriovenous malformation. , 1996, Chest.

[32]  C. Shovlin,et al.  Inherited diseases of the vasculature. , 1996, Annual review of physiology.

[33]  J. Lammers,et al.  Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. , 1996, Archives of internal medicine.

[34]  R. Fulbright,et al.  MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. , 1998, AJNR. American journal of neuroradiology.

[35]  S. Coley,et al.  Pulmonary arteriovenous malformations. , 1998, Clinical radiology.

[36]  C. Shovlin.  Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia. , 1998, Clinical science.

[37]  D. Dumont,et al.  A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.

[38]  J. Viale,et al.  Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. , 1999, Gastroenterology.

[39]  J. Wrana,et al.  Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily* , 1999, The Journal of Biological Chemistry.

[40]  A. Kjeldsen,et al.  Hereditary haemorrhagic telangiectasia: a population‐based study of prevalence and mortality in Danish patients , 1999, Journal of internal medicine.

[41]  C. Shovlin,et al.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms , 1999, Thorax.

[42]  C. Shovlin.  Supermodels and disease: insights from the HHT mice. , 1999, The Journal of clinical investigation.

[43]  V. Lund,et al.  A Treatment Algorithm for the Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia , 1999, American journal of rhinology.

[44]  A. Guttmacher,et al.  Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. , 2000, The American journal of pathology.

[45]  K. terBrugge,et al.  Analysis of Endoglin Expression in Normal Brain Tissue and in Cerebral Arteriovenous Malformations , 2000, Stroke.

[46]  J. Mager,et al.  Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. , 2000, Journal of neurosurgery.

[47]  D. Marchuk,et al.  Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. , 2000, Developmental biology.

[48]  Dean Y. Li,et al.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.

[49]  D. Jain,et al.  Liver disease in patients with hereditary hemorrhagic telangiectasia. , 2000, The New England journal of medicine.

[50]  J. Kjeldsen,et al.  Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia , 2000, American Journal of Gastroenterology.

[51]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[52]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Humbert,et al.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.

[54]  Robert D. Brown,et al.  Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia , 2001, Stroke.

[55]  S. Steinberg,et al.  A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  C. Sabbà,et al.  Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.

[57]  P. Thall,et al.  Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck , 2001, Cancer.

[58]  D. Parums,et al.  Inducible expression of human endoglin during inflammation and wound healing in vivo , 2002, Inflammation Research.

[59]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[60]  P. Barnes,et al.  Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). , 2002, Pediatrics.

[61]  J. B. Bello López,et al.  Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia? , 2002, Haematologica.

[62]  T. Shioya,et al.  Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan , 2002, Human mutation.

[63]  R. Kurstin,et al.  Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease. , 2002, Oncology.

[64]  Pat Kumar,et al.  TNFα down-regulates CD105 expression in vascular endothelial cells: A comparative study with TGFβ1 , 2003 .

[65]  Dean Y. Li,et al.  Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. , 2003, Developmental biology.

[66]  M. Porteous,et al.  A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. , 2003, Human molecular genetics.

[67]  C. Shovlin,et al.  Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century , 2003, Postgraduate medical journal.

[68]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[69]  A. Paterson,et al.  Cerebral Vascular Abnormalities in a Murine Model of Hereditary Hemorrhagic Telangiectasia , 2003, Stroke.

[70]  J. Hughes,et al.  Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life , 2003, Journal of neurology, neurosurgery, and psychiatry.

[71]  R. Trembath,et al.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia , 2003, Journal of medical genetics.

[72]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[73]  C. Westermann,et al.  The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro‐Caribbean population of the Netherlands Antilles: A family screening , 2003, American journal of medical genetics. Part A.

[74]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[75]  A. Rustgi,et al.  A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) , 2004, The Lancet.

[76]  L. Di Gennaro,et al.  Health-related quality of life in a rare disease: Hereditary hemorrhagic telangiectasia (HHT) or Rendu–Osler–Weber Disease , 2004, Quality of Life Research.

[77]  G. Garcı́a-Cardeña,et al.  Early adaptive responses of the vascular wall during venous arterialization in mice. , 2004, The American journal of pathology.

[78]  V. Cottin,et al.  Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. , 2004, American journal of respiratory and critical care medicine.

[79]  Omar I. Massoud,et al.  Resolution of hereditary hemorrhagic telangiectasia and anemia with prolonged alpha-interferon therapy for chronic hepatitis C. , 2004, Journal of clinical gastroenterology.

[80]  M. Goumans,et al.  Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.

[81]  D. Marchuk,et al.  Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia , 2004, European Respiratory Journal.

[82]  M. Goumans,et al.  Defective paracrine signalling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia , 2004 .

[83]  M. Letarte,et al.  No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia , 2004, Journal of Medical Genetics.

[84]  D. Lindhout,et al.  Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients , 2004, Human Genetics.

[85]  T. Krings,et al.  Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations , 2005, Neuroradiology.

[86]  K. Hörmann,et al.  Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. , 2005, Haematologica.

[87]  K. Brusgaard,et al.  Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia , 2005, Journal of internal medicine.

[88]  C. Shovlin,et al.  Interferon for metastatic renal cell cancer causing regression of hereditary hemorrhagic telangiectasia. , 2005, Journal of clinical gastroenterology.

[89]  F. Blanco,et al.  Interaction and functional interplay between endoglin and ALK‐1, two components of the endothelial transforming growth factor‐β receptor complex , 2005, Journal of cellular physiology.

[90]  V. Lund,et al.  The SF-36 Health Status Questionnaire in Assessing Patients with Epistaxis Secondary to Hereditary Hemorrhagic Telangiectasia , 2005, American journal of rhinology.

[91]  J. Wrana,et al.  Endoglin Null Endothelial Cells Proliferate Faster and Are More Responsive to Transforming Growth Factor β1 with Higher Affinity Receptors and an Activated Alk1 Pathway* , 2005, Journal of Biological Chemistry.

[92]  N. Pece-Barbara,et al.  Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1. , 2005, Cardiovascular research.

[93]  A. Woodhouse.  Evidence and practice. , 2005, Mental health today.

[94]  K. Hörmann,et al.  Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. , 2005, International journal of molecular medicine.

[95]  C. Shovlin,et al.  A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5 , 2005, Journal of Medical Genetics.

[96]  D. Eidelman,et al.  Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013A Role for Endoglin in Coupling eNOS Activity and Regulating Vascular Tone Revealed in Hereditary , 2022 .

[97]  T. Krings,et al.  Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age , 2005, Neuroradiology.

[98]  H. Alvarez,et al.  Spinal arteriovenous shunts presenting before 2 years of age: analysis of 13 cases , 2006, Child's Nervous System.

[99]  G. Rao,et al.  Pediatric arteriovenous malformations: a 15-year experience with an emphasis on residual and recurrent lesions , 2006, Child's Nervous System.

[100]  M. Letarte,et al.  Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease , 2005, Journal of Medical Genetics.

[101]  B. Gallie,et al.  Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations , 2006, Journal of Medical Genetics.

[102]  M. Krawczak,et al.  Hereditary hemorrhagic telangiectasia is caused by the Q490X mutation of the ACVRL1 gene in a large Arab family: support of homozygous lethality. , 2006, European journal of medical genetics.

[103]  F. D'Ovidio,et al.  Life expectancy in patients with hereditary haemorrhagic telangiectasia. , 2006, QJM : monthly journal of the Association of Physicians.

[104]  V. Thijs,et al.  Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine , 2006, Neurology.

[105]  D. Lindhout,et al.  Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia , 2005, Journal of Medical Genetics.

[106]  W. Fischbach,et al.  Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab , 2006, Annals of Hematology.

[107]  P. Bayrak-Toydemir,et al.  Genotype–phenotype correlation in hereditary hemorrhagic telangiectasia: Mutations and manifestations * , 2006, American journal of medical genetics. Part A.

[108]  J. Massagué,et al.  The logic of TGFβ signaling , 2006 .

[109]  Robert I. White,et al.  Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[110]  P. Bayrak-Toydemir,et al.  A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7 , 2006, American journal of medical genetics. Part A.

[111]  J. Edmeads,et al.  Migraines Linked to Intrapulmonary Right‐to‐Left Shunt , 2006, Headache.

[112]  E. Buscarini,et al.  Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia , 2006, Genetics in Medicine.

[113]  J. Belghiti,et al.  Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry , 2006, Annals of surgery.

[114]  J. Remy,et al.  Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up. , 2006, Radiology.

[115]  E. Jirillo,et al.  Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT. , 2006, Current pharmaceutical design.

[116]  A. Ganguly,et al.  Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype , 2006, Human mutation.

[117]  Robert I. White,et al.  Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. , 2006, Journal of vascular and interventional radiology : JVIR.

[118]  R. White,et al.  Cerebral embolism—First manifestation of pulmonary arteriovenous malformation in patient with hereditary hemorrhagic telangiectasia , 1985, CardioVascular and Interventional Radiology.

[119]  C. Morales-Angulo,et al.  Tratamiento de las epistaxis en la telangiectasia hemorrágica hereditaria (enfermedad de Rendu-Osler-Weber) con ácido tranexámico , 2007 .

[120]  M. V. Dinther,et al.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.

[121]  D. Goff,et al.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardi , 2007, Journal of the American Dental Association.

[122]  J. Honnorat,et al.  Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network , 2007, Genetics in Medicine.

[123]  Richard Pazdur,et al.  FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer. , 2007, The oncologist.

[124]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[125]  Africa Fernández-L,et al.  Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): Regulation of ALK-1/endoglin pathway in endothelial cells , 2007, Thrombosis and Haemostasis.

[126]  E. Kulinskaya,et al.  Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia , 2007, Thorax.

[127]  P. Dijke,et al.  Extracellular control of TGFβ signalling in vascular development and disease , 2007, Nature Reviews Molecular Cell Biology.

[128]  C. Sabbà,et al.  Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers , 2007, Journal of thrombosis and haemostasis : JTH.

[129]  C. Shovlin,et al.  Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): Association with venous thromboembolism , 2007, Thrombosis and Haemostasis.

[130]  F. Sanz‐Rodríguez,et al.  [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid]. , 2007, Acta otorrinolaringologica espanola.

[131]  Robert I. White,et al.  Septectomy and Septal Dermoplasty for the Treatment of Severe Transfusion-Dependent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia and Septal Perforation , 2007, American journal of rhinology.

[132]  V. Cottin,et al.  Long-term follow-up in 12 children with pulmonary arteriovenous malformations: confirmation of hereditary hemorrhagic telangiectasia in all cases. , 2007, The Journal of pediatrics.

[133]  K. Zukotynski,et al.  Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT. , 2007, Chest.

[134]  J. Remy,et al.  Pulmonary arteriovenous malformation treated with embolotherapy: systemic collateral supply at multidetector CT angiography after 2-20-year follow-up. , 2007, Radiology.

[135]  D. Frush,et al.  Review of radiation risks from computed tomography: essentials for the pediatric surgeon. , 2007, Journal of pediatric surgery.

[136]  T. Davidson,et al.  Use of a Sprayed Fibrin Hemostatic Sealant after Laser Therapy for Hereditary Hemorrhagic Telangiectasia Epistaxis , 2007, American journal of rhinology.

[137]  M. Goumans,et al.  Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ receptors in mice , 2007, Journal of Cell Science.

[138]  Varda Shalev,et al.  Excess lifetime cancer mortality risk attributable to radiation exposure from computed tomography examinations in children. , 2007, The Israel Medical Association journal : IMAJ.

[139]  D. Miller,et al.  Radiation Dose to the Brain and Subsequent Risk of Developing Brain Tumors in Pediatric Patients Undergoing Interventional Neuroradiology Procedures , 2008, Radiation research.

[140]  W. Vandertop,et al.  Gamma knife surgery and arteriovenous malformations. , 2008, Journal of neurosurgery. Pediatrics.

[141]  A. Shapiro,et al.  Hereditary haemorrhagic telangiectasia , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[142]  E. Lyon,et al.  Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a model. , 2008, Experimental and molecular pathology.

[143]  K. Bamford,et al.  Post-NICE 2008: antibiotic prophylaxis prior to dental procedures for patients with pulmonary arteriovenous malformations (PAVMs) and hereditary haemorrhagic telangiectasia , 2008, BDJ.

[144]  M. Shoukier,et al.  Characterization of five novel large deletions causing hereditary haemorrhagic telangiectasia , 2008, Clinical genetics.

[145]  E. Génin,et al.  Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients , 2008, European Journal of Human Genetics.

[146]  A. Bowen,et al.  National Clinical Guideline for Stroke , 2008 .

[147]  A. Hinck,et al.  Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. , 2008, Molecular cell.

[148]  C. Shovlin,et al.  Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure , 2008, European Respiratory Journal.

[149]  K. Swanson,et al.  Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: In search of predictors of significant disease , 2008, Hepatology.

[150]  P. Espinosa,et al.  Hereditary hemorrhagic telangectasia and spinal cord infarct: Case report with a review of the neurological complications of HHT , 2008, Clinical Neurology and Neurosurgery.

[151]  C. Shovlin,et al.  Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler–Weber–Rendu syndrome): suggested approach for obstetric services , 2008, BJOG : an international journal of obstetrics and gynaecology.

[152]  V. Kaartinen,et al.  ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. , 2008, Blood.

[153]  J. Saurin,et al.  Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences , 2008, Hepatology.

[154]  M. Tymianski,et al.  Management and clinical outcome of posterior fossa arteriovenous malformations: report on a single-centre 15-year experience , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[155]  T. Stokes,et al.  Prophylaxis against infective endocarditis for dental procedures – summary of the NICE guideline , 2008, BDJ.

[156]  V. Lund,et al.  The Impact of Septodermoplasty and Potassium-Titanyl-Phosphate (KTP) Laser Therapy in the Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis , 2008, American journal of rhinology.

[157]  L. Adams,et al.  Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[158]  J. Leach,et al.  Guideline Development Group , 2008 .

[159]  P. Zanen,et al.  Genotype–phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia , 2008, American journal of medical genetics. Part A.

[160]  E. Buscarini,et al.  Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: A word of caution , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[161]  F. Brunelle,et al.  Acute paraplegia due to spinal arteriovenous fistula in two patients with hereditary hemorrhagic telangiectasia , 2009, European Journal of Pediatrics.

[162]  Neil Vargesson,et al.  Thalidomide‐induced limb defects: resolving a 50‐year‐old puzzle , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[163]  C. Betsholtz,et al.  Endothelial-mural cell signaling in vascular development and angiogenesis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[164]  R. Trembath,et al.  Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells* , 2009, The Journal of Biological Chemistry.

[165]  J. Mager,et al.  Life-Expectancy of Parents with Hereditary Hemorrhagic Telangiectasia. , 2009, ATS 2009.

[166]  J. Repke,et al.  Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study , 2009, European Respiratory Journal.

[167]  P. Bayrak-Toydemir,et al.  Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: illustration of complexity in molecular diagnostic interpretation. , 2009, The Journal of molecular diagnostics : JMD.

[168]  Xiao-Fan Wang,et al.  Signaling cross-talk between TGF-β/BMP and other pathways , 2009, Cell Research.

[169]  A. Guttmacher,et al.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia , 2009, Journal of Medical Genetics.

[170]  C. Shovlin,et al.  Hereditary haemorrhagic telangiectasia: a clinical and scientific review , 2009, European Journal of Human Genetics.

[171]  F. Zhan,et al.  Thrombotic events in patients with cancer receiving antiangiogenesis agents. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[172]  S. Evers,et al.  An Association of Migraine with Hereditary Haemorrhagic Telangiectasia Independently of Pulmonary Right-to-Left Shunts , 2009, Cephalalgia : an international journal of headache.

[173]  C. Pedrinazzi,et al.  Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter? , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[174]  C. Shovlin,et al.  Management of pulmonary arteriovenous malformations in pulmonary hypertensive patients: a pressure to embolise? , 2009, European Respiratory Review.

[175]  R. Henkelman,et al.  Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[176]  Stroke following pulmonary arteriovenous fistula embolization in a patient with HHT. , 2009 .

[177]  M. Post,et al.  Grading of pulmonary right-to-left shunt with transthoracic contrast echocardiography: does it predict the indication for embolotherapy? , 2009, Chest.

[178]  C. Tinelli,et al.  Correlation of Severity of Epistaxis with Nasal Telangiectasias in Hereditary Hemorrhagic Telangiectasia (HHT) Patients , 2009, American journal of rhinology & allergy.

[179]  Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis. , 2009, Rhinology.

[180]  T. Davidson,et al.  The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia , 2009, The Laryngoscope.

[181]  G. Borthwick,et al.  Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH , 2009, Laboratory Investigation.

[182]  B. Sorg,et al.  Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. , 2009, The Journal of clinical investigation.

[183]  CLASSIC ESSENTIAL TREMOR CHANGES FOLLOWING CEREBELLAR HEMORRHAGE. Authors' reply , 2009 .

[184]  T. Hadar,et al.  Antiestrogen therapy for hereditary hemorrhagic telangiectasia: A double‐blind placebo‐controlled clinical trial , 2009, The Laryngoscope.

[185]  Neil Vargesson,et al.  Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation , 2009, Proceedings of the National Academy of Sciences.

[186]  A. Terzić,et al.  Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[187]  P. Zanen,et al.  The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study. , 2009, Rhinology.

[188]  L. Botella,et al.  Graded contrast echocardiography in pulmonary arteriovenous malformations , 2009, European Respiratory Journal.

[189]  P. Carmeliet,et al.  Development of targeted angiogenic medicine , 2009, Journal of thrombosis and haemostasis : JTH.

[190]  M. Mei-Zahav,et al.  Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia , 2009, European Respiratory Journal.

[191]  Rachael J. Oakenfull,et al.  Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin , 2010, Circulation research.

[192]  S. Bianca,et al.  Hereditary haemorrhagic telangiectasia and genetic thrombophilia , 2010, European Journal of Human Genetics.

[193]  Reply to Bianca et al , 2010, European Journal of Human Genetics.

[194]  C. Shovlin,et al.  Embolization of pulmonary arteriovenous malformations using the Amplatzer vascular plug: successful treatment of 69 consecutive patients , 2010, European Radiology.

[195]  P. Bayrak-Toydemir,et al.  Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family , 2010, Clinical genetics.

[196]  Marie-José Goumans,et al.  Signaling by members of the TGF-beta family in vascular morphogenesis and disease. , 2010, Trends in cell biology.

[197]  M. Post,et al.  Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study. , 2010, Chest.

[198]  J. Saurin,et al.  Long‐term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: A single‐center study , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[199]  Robert I. White,et al.  Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP–HHT syndrome , 2010, American journal of medical genetics. Part A.

[200]  Lisa X. Yu,et al.  Spontaneous Adult-Onset Pulmonary Arterial Hypertension Attributable to Increased Endothelial Oxidative Stress in a Murine Model of Hereditary Hemorrhagic Telangiectasia , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[201]  G. Soulez,et al.  Embolization of pulmonary arteriovenous malformations with amplatzer vascular plugs: safety and midterm effectiveness. , 2010, Journal of vascular and interventional radiology : JVIR.

[202]  C. Shovlin,et al.  Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes , 2010, Journal of angiogenesis research.

[203]  C. Mummery,et al.  Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia , 2010, Nature Medicine.

[204]  The war in my head: coping with arteriovenous malformation after a brain haemorrhage , 2010, BMJ : British Medical Journal.

[205]  R. Akhurst.  Taking thalidomide out of rehab , 2010, Nature Medicine.

[206]  D. Postoak,et al.  Transjugular intrahepatic portosystemic shunt for variceal hemorrhage due to recurrent of hereditary hemorrhagic telangiectasia in a liver transplant. , 2010, Journal of vascular and interventional radiology : JVIR.

[207]  T. Davidson,et al.  Hereditary hemorrhagic telangiectasia/avastin , 2010, The Laryngoscope.

[208]  D. Tregouet,et al.  Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. , 2010, American journal of respiratory and critical care medicine.

[209]  J. Roume,et al.  Pancreatic involvement in hereditary hemorrhagic telangiectasia: assessment with multidetector helical CT. , 2010, Radiology.

[210]  C. Bernabéu,et al.  Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells , 2010, Thrombosis and Haemostasis.

[211]  C. Merlo,et al.  An epistaxis severity score for hereditary hemorrhagic telangiectasia , 2010, The Laryngoscope.

[212]  C. D. Owens,et al.  Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. , 2010, Journal of vascular surgery.

[213]  J. López-Novoa,et al.  The physiological role of endoglin in the cardiovascular system. , 2010, American journal of physiology. Heart and circulatory physiology.